Saba Capital Management L.P. Takes Position in BlackRock Health Sciences Term Trust $BMEZ

Saba Capital Management L.P. acquired a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) in the 1st quarter, Holdings Channel reports. The firm acquired 759,506 shares of the company’s stock, valued at approximately $10,907,000.

A number of other institutional investors and hedge funds have also made changes to their positions in BMEZ. Lazard Asset Management LLC raised its holdings in BlackRock Health Sciences Term Trust by 64.2% in the first quarter. Lazard Asset Management LLC now owns 621,604 shares of the company’s stock valued at $8,926,000 after acquiring an additional 243,054 shares in the last quarter. Quantedge Capital Pte Ltd grew its holdings in BlackRock Health Sciences Term Trust by 85.0% during the 1st quarter. Quantedge Capital Pte Ltd now owns 135,854 shares of the company’s stock worth $1,951,000 after acquiring an additional 62,400 shares in the last quarter. PNC Financial Services Group Inc. acquired a new position in BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $35,000. SouthState Bank Corp acquired a new position in BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $29,000. Finally, Calamos Advisors LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 1st quarter valued at approximately $740,000.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BMEZ opened at $15.34 on Tuesday. BlackRock Health Sciences Term Trust has a twelve month low of $13.67 and a twelve month high of $15.80. The firm’s fifty day simple moving average is $14.85 and its 200-day simple moving average is $14.73.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a dividend of $0.11 per share. The ex-dividend date is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 8.6%.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.